Analysts say TrumpRx, the Trump administration's consumer drug-pricing site, might not deliver lower drug prices for most ...

An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.

President Donald Trump has said that Americans are now paying or will pay "the lowest price anywhere in the world for drugs," thanks to the administration’s negotiations with pharmaceutical companies.

RISING health care costs could lead to tighter government price controls, a Fitch Group unit said, creating headwinds for pharmaceutical companies and speeding up a shift toward cheaper generics. “The ...

The use of biosimilars saved Blue Cross members and employee groups $67 million in 2024 and $80 million in 2025, according to a news release. The savings come amid a cost-cutting push at Blue Cross to ...

Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...

A newly-launched government-branded prescription platform, TrumpRx, is being promoted to lower drug costs. But will it actually save Black patients money? How does it work — and who is it really ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

The new TrumpRx scam being rolled out by the America First Crime Family is aimed at the people who voted him back into the White House.

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal ...